KIONEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kionex, and when can generic versions of Kionex launch?
Kionex is a drug marketed by Ani Pharms and is included in two NDAs.
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kionex
A generic version of KIONEX was approved as sodium polystyrene sulfonate by CMP PHARMA INC on January 19th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KIONEX?
- What are the global sales for KIONEX?
- What is Average Wholesale Price for KIONEX?
Summary for KIONEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Drug Prices: | Drug price information for KIONEX |
| DailyMed Link: | KIONEX at DailyMed |
US Patents and Regulatory Information for KIONEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | KIONEX | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 040029-001 | Feb 6, 1998 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | KIONEX | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 040028-001 | Sep 17, 2007 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
